View source for Zeltia

{{Use mdy dates|date=July 2021}}
{{Infobox company
| name             = Zeltia, S.A.
| logo             = Zeltia-logo.jpg
| logo_size        = 200px
| caption          =
| trading_name     = <!-- d/b/a/, doing business as - if different from legal name above -->
| native_name      = <!-- Company's name in home country language -->
| native_name_lang = <!-- Use ISO 639-2 code, e.g. "fr" for French. If there is more than one native name, in different languages, enter those names using {{tl|lang}}, instead. -->
| romanized        =
| former type      =
| type             = [[S.A. (corporation)|Sociedad Anónima]]
| traded_as        = {{BMAD|ES0184940817|ZEL}}
| ISIN = {{ISIN|sl=n|pl=y|ES0184940817}}
| industry         = [[Pharmaceutical industry|Pharmaceutical]]
| genre            = <!-- Only used with media and publishing companies -->
| fate             =
| predecessor      =
| successor        =
| foundation       = [[Vigo]], Galicia, Spain ({{Start date|1939|08|03}})
| founder          =
| defunct          = {{end date|2015}}
| location_city    = Madrid
| location_country = Spain
| locations        =
| area_served      = Worldwide
| key_people       = José Fernández Sousa-Faro (Chairman)
| products         = Pharmaceuticals
| production       =
| services         =
| revenue          = {{increase}} US$176&nbsp;million (2009)
| operating_income = {{increase}} (US$46.3) million (2009)
| net_income       = {{increase}} (US$40.3) million (2009)
| aum              = <!-- Only used with financial services companies -->
| assets           = {{increase}} US$302.9&nbsp;million (2009)
| equity           = {{decrease}} US$59&nbsp;million (2009)
| owner            =
| num_employees    =
| parent           =
| divisions        =
| subsid           = PharmaMar, Genómica, Sylentis, Zelnova, Xylazel
| homepage         = {{URL|www.zeltia.com/}}
| footnotes        =<ref name="hoovers" group="finan" /><ref name="Bueno2008" group="history"/>
| intl             =
| bodystyle        =
}}
'''Zeltia''' is a former Spanish pharmaceutical company which operated through a variety of subsidiaries in the pharmaceutical and chemical industries.  As of 2007, Zeltia's research activities in the pharmaceutical area had not resulted in a marketed product.<ref group="history" name="Clark2007"/> However, the company's majority shareholder and chairman are the same person, which has relieved the pressure which many CEOs have experienced to produce immediate returns.<ref group="history" name="Jericó2009"/>
==History==
In 1993 Zeltia sells its subsidiary Cooper-Zeltia taking the name [[Zendal|CZ Veterinaria]], which years later would be renamed [[Zendal]].<ref>{{Cite web|url=https://www.lavozdegalicia.es/noticia/extravoz/2015/08/30/pueblo-levanto-industria/00031440771453409364104.htm|title=El pueblo que levantó una industria|date=August 31, 2015|website=La Voz de Galicia}}</ref>
The company was taken over by its subsidiary [[Pharma Mar]] in a reverse takeover, keeping the Zeltia's Group structure.
In 2018 PharmaMar sells Xylazel to the Dutch company AkzoNobel.<ref>{{Cite web |title=Pharma Mar vende su química gallega Xylazel por 21,8 millones » Galicia |url=https://www.economiadigital.es/galicia/empresas/pharma-mar-vende-su-quimica-gallega-xylazel-por-21-8-millones_578438_102.html |access-date=2022-07-25 |language=es}}</ref><ref>{{Cite web |last=Construcción |first=Alimarket |title=Akzo Nobel compra la fabricante gallega Xylazel - Noticias de Construcción en Alimarket, información económica sectorial |url=https://www.alimarket.es/construccion/noticia/285177/akzo-nobel-compra-la-fabricante-gallega-xylazel |access-date=2022-07-25 |website=Alimarket.es |language=es}}</ref>
In 2019 PharmaMar sells Zelnova, the group's last subsidiary in Galicia, to the Galician investment company Allentia Invest for 33 million euros.<ref>{{Cite web |last=Ropero |first=Javier García |date=2020-08-24 |title=Zelnova buscará compras y crecer en el exterior para facturar 100 millones en 2024 |url=https://cincodias.elpais.com/cincodias/2020/08/23/companias/1598199125_366853.html |access-date=2022-07-25 |website=Cinco Días |language=es}}</ref>
==Subsidiaries==
Direct [[Subsidiary|subsidiaries]] as of 2009 were:<ref group="finan" name="2009annual"/> Pharma Mar, S.A.U.; Genómica, S.A.U.; Zelnova, S.A; Protección de Maderas, S.A.U; Xylazel, S.A.; Noscira, S.A.; Sylentis, S.A.
Indirect subsidiaries which are direct subsidiaries of Pharma Mar as of 2009 were:<ref group="finan" name="2009annual"/> Pharma Mar US; Pharma Mar AG; PharmaMar S.A.R.L.; Pharma Mar GmbH; Pharma Mar Ltd.
A single indirect subsidiary is a direct subsidiary of Zelnova, that being Copyr, S.p.A.<ref group="finan" name="2009annual"/>
==References==
{{Reflist}}
===Financial===
<references group="finan">
<ref name="hoovers">{{cite web |url=http://www.hoovers.com/company/Zeltia_SA/rfrxfki-1.html |access-date=May 7, 2011 |title=Zeltia, S.A. |publisher=[[Hoover's]] |location=Austin, Texas, United States |at=Companies |format=database record }}</ref>
<ref name="2009annual">{{cite web |url=http://www.zeltia.com/analistas_inversores.cfm
|title=Consolidated Financial Statements as of 31 December 2009 |date=April 16, 2010 |publisher=Zeltia |access-date=May 7, 2011 }}</ref>
</references>
===History===
<references group="history">
<ref name="Clark2007">{{Citation |last=Clark |first=Todd D.
|title=PharmaHandbook: a guide to the international pharmaceutical industry |isbn=978-0-9795443-0-9 |oclc=254331162
|type=Google Books |access-date=May 7, 2011 |edition=5 |year=2007 |page=381 |chapter=Spain
|chapter-url=https://books.google.com/books?id=E-qs6BtdIUAC&q=zeltia&pg=PA381
|publisher=Value of Insight Consulting |location=New Orleans, Louisiana, United States }}</ref>
<ref name="Jericó2009">{{Citation |last=Jericó |first=Pilar |title=No Fear: In Business and In Life
|type=Google Books |chapter-url=https://books.google.com/books?id=XHQFHz47oGcC&q=Zeltia&pg=PA66
|access-date=May 7, 2011 |year=2009 |publisher=[[Palgrave Macmillan]] |location=Basingstoke, United Kingdom
|isbn=978-0-230-58038-1 |oclc=636422030 |page=66 |chapter=The Price of Fear }}</ref>
<ref name="Bueno2008">{{Citation |last=Bueno |first=María José Sánchez |page=175 |isbn=978-84-9745-240-3 |oclc=434255490
|title=El proceso innovador y tecnológico: estrategias y apoyo público |type=Google Books
|url=https://books.google.com/books?id=pz1vRJ-mhVEC&q=zeltia&pg=PA175
|access-date=May 7, 2011 |year=2008 |publisher=[[Netbiblo]] |language=es }}</ref>
</references>
{{Authority control}}
[[Category:Pharmaceutical companies established in 1939]]
[[Category:1939 establishments in Spain]]
[[Category:Companies based in the Community of Madrid]]
[[Category:Pharmaceutical companies of Spain]]
[[Category:Chemical companies of Spain]]
[[Category:Companies listed on the Madrid Stock Exchange]]
[[Category:Companies based in Galicia (Spain)]]